Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc7693dae06e6b3ff39c820ec91bf5db |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0032 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0402 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0406 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0497 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 |
filingDate |
2015-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_626446eafbb99f3a236fc736b09abfb8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcd02336ca0d18b6efb5e6e1d5311874 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0841700381f9bd38dc5cfca92e0115f7 |
publicationDate |
2017-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9713649-B2 |
titleOfInvention |
PSMA-targeting imaging agents |
abstract |
A PSMA-specific imaging agent comprising a compound according to formula I: n nare described, wherein S 1 is an organic spacer group having from 5 to 30 carbons, A is an amino acid forming a portion of a negatively charged peptide oligomer, n is from 3 to 6, S 2 is an organic spacer group having from 5 to 15 carbons, and I is an imaging group, and pharmaceutically acceptable salts thereof. The PSMA-specific imaging agents can be used to image PSMA within a tissue region to guide the treatment of diseases such as prostate cancer. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10918741-B2 |
priorityDate |
2014-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |